Opening question: When the same peptide name shows up in an approved medicine label and in a research catalog screenshot, how do you use DailyMed without confusing the two?
Short answer: treat DailyMed as NLM’s searchable library of labeling submitted to FDA and currently in use—useful for checking indications, limitations, and warnings on labeled products. A research catalog entry is not “in-use labeling,” even when it reuses a familiar chemical name.
The National Library of Medicine’s DailyMed homepage states that the database contains labeling submitted to FDA by companies, that DailyMed does not contain a complete listing of all FDA-regulated product labeling, and that NLM provides DailyMed to the public without advertisements. In other words: it is a label lookup tool, not a marketplace and not a guarantee that every vial online has a matching label.
A concrete contrast: search DailyMed for the approved product EGRIFTA SV (tesamorelin). The label identifies it as a growth hormone-releasing factor analog, notes initial U.S. approval in 2010, and states an indication for reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy—while also listing limitations of use (including that long-term cardiovascular safety has not been established and that it is not indicated for weight-loss management). That is prescription-label literacy. Separately, WADA’s Prohibited List still names tesamorelin among GHRH analogues under S2—so sport status and labeled medical use are different questions.
DailyMed reading checklist when a peptide name appears in ads:
- Is there an in-use label at all? If DailyMed search returns no matching human prescription label, do not invent one from a catalog screenshot.
- Read Indications and Limitations first: Approved use is narrow and written. Social “same molecule, same benefits” claims often skip limitations and contraindications.
- Separate label from research merchandise: NIH ODS materials on dietary supplements describe a different regulatory category than prescription labeling; research-use-only COAs are another category again.
- Do not treat the label as DIY instructions: Patient labeling exists for prescribed use under clinician care—not for copying doses from screenshots into research vials.
For company facts only—not clinical evidence—Apollo Peptides states products are for laboratory research only, not for human or veterinary use.
Bottom line: Use DailyMed to check whether a peptide name has current FDA-submitted labeling and what that label actually says. Matching syllables in a catalog title is not the same as an approved, in-use drug label.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against DailyMed’s about text, the opened EGRIFTA SV label page, and the company site on 2026-09-21 PT. No invented studies or self-use dosing. Not medical advice.
Sources
1. NLM DailyMed — database of labeling submitted to FDA
2. DailyMed — EGRIFTA SV (tesamorelin) prescribing information
3. Apollo Peptides (company facts only)
Related reading
GLP-1 prescription news literacy vs research-peptide catalog screenshots
OTC Drug Facts literacy vs. research-peptide vial screenshots
What “research use only” and a COA mean when ads blur supplements and vials